Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA ; volume:34 ; number:11 ; day:16 ; month:10 ; year:2017 ; pages:2422-2435 ; date:11.2017
Advances in therapy ; 34, Heft 11 (16.10.2017), 2422-2435, 11.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Chastek, Benjamin
- Beteiligte Personen und Organisationen
-
Chen, Chieh-I
Proudfoot, Clare
Shinde, Shraddha
Kuznik, Andreas
Wei, Wenhui
SpringerLink (Online service)
- DOI
-
10.1007/s12325-017-0617-5
- URN
-
urn:nbn:de:1111-20180201617
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.04.2025, 09:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chastek, Benjamin
- Chen, Chieh-I
- Proudfoot, Clare
- Shinde, Shraddha
- Kuznik, Andreas
- Wei, Wenhui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment persistence of biologics among patients with psoriatic arthritis
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Long memory and changing persistence
Real-world retention rates of biologics in patients with rheumatoid arthritis
“Life-changing”: the experience of super-responders to biologics in severe asthma
Methotrexate treatment before use of biologics in rheumatoid arthritis: Analysis of guideline compliance
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment
Biologics in therapy
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review
Serum level of IFNβ distinguishes early from late relapses after biologics withdrawal in rheumatoid arthritis
Treatment persistence of biologics among patients with psoriatic arthritis
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Long memory and changing persistence
Real-world retention rates of biologics in patients with rheumatoid arthritis
“Life-changing”: the experience of super-responders to biologics in severe asthma
Methotrexate treatment before use of biologics in rheumatoid arthritis: Analysis of guideline compliance
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment
Biologics in therapy
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review
Serum level of IFNβ distinguishes early from late relapses after biologics withdrawal in rheumatoid arthritis
Treatment persistence of biologics among patients with psoriatic arthritis
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Long memory and changing persistence
Real-world retention rates of biologics in patients with rheumatoid arthritis
“Life-changing”: the experience of super-responders to biologics in severe asthma
Methotrexate treatment before use of biologics in rheumatoid arthritis: Analysis of guideline compliance
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment
Biologics in therapy
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review